Insomnias. II. Pharmacological and psychotherapeutic treatment options;Insomnien II. Pharmakologische und psychotherapeutische Behandlungsmöglichkeiten

Nervenarzt

Volumn 80, Issue 11, 2009, Pages 1327-1340

  Riemann, D ^a   Hajak, G ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cognitive behavioural therapy; Insomnias; Pharmacotherapy

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; HYPNOTIC AGENT; MELATONIN; VALERIAN;

CLINICAL TRIAL; COGNITIVE THERAPY; HUMAN; INSOMNIA; OFF LABEL DRUG USE; PHARMACEUTICAL CARE; PSYCHIATRIC TREATMENT; PSYCHOEDUCATION; PSYCHOTHERAPY; RELAXATION TRAINING; REVIEW;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; PREVALENCE; PSYCHOTHERAPY; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 71249121766     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-009-2746-9     Document Type: Review

References (66)

1. Ancoli-lsrael S, Richardson GS, Mangano RM et al. (2005) Long-term use of sedative hypnotics In older patients with insomnia. Sleep Med 6:107-113 (Pubitemid 40247172)
2. Backhaus J, Riemann D (1996) Schlafstörungen bewältigen. Informationen und Anleitung zur Selbsthilfe. Beltz, Weinheim
3. Backhaus J, Riemann D (1999) Schlafstörungen. Fortschritte der Psychotherapie. Bd. VII. Hogrefe, Göttingen
4. Backhaus J, Hohagen F.Voderholzer U, Riemann D (2001 ) Long-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia. Eur Arch Psychiatry Clin Neurosci 251:35-41 (Pubitemid 32267314)
5. Ballard C, Howard R (2006) Neuroleptic drugs in dementia: Benefits and harm. Nat Rev Neurosci 7:492-500 (Pubitemid 44012289)
6. Bent S, Padula A, Moore D et al. (2006) Valerian for sleep: A systematic review and meta-analysis. Am J Med 119:1005-1012 (Pubitemid 44826933)
7. Bootzin RR (1972) A stimulus control treatment for insomnia. In: Proceedings of the 80th Annual Convention of the American Psychological Association. APA, Washington, pp 395-396
8. Borbély AA (1982) A two process model of sleep regulation. Hum Neurobiol 1:195-204
9. Buscemi N, Vandermeer B, Hooton N et al. (2005) The efficacy and safety of exogenous melatonin for primary sleep disorders. J Gen Intern Med 20:1151-1158
10. Buscemi N, Vandermeer B, Hooton N et al. (2006) Efficacy and safety of exogenous melatonin for secondary sleep disorders accompanying sleep restriction: Meta-analysis. BMJ published online 10 February:1-9
11. Chesson AL, Mc Dowell AW, Littner M et al. (1999) Practice parameters for the nonpharmacological treatment of chronic insomnia. Sleep 22:11281133
12. DeMartinis NA, Winokur A (2007) Effects of psychiatric medications on sleep and sleep disorders. CNS Neurol Disord Drug Targets 6:17-29 (Pubitemid 46322292)
13. Duendar Y, Boland J, Strobl J et al. (2004) Newer hypnotic drugs for the short-term management of insomnia: A systematic review and economic evaluation. Health Technol Assess 8:24
14. Duendar Y, Dodd S, Strobl J et al. (2004) Comparative efficacy of newer hypnotic drugs for the shortterm management of insomnia: A systematic review and meta-analysis. Hum Psychopharmacol 19:305-322 (Pubitemid 39106872)
15. EMEA (2007) http://www.emea.europa.eu/hu-mandocs/PDFs/EPAR/circadin/H- 695-de1.pdf
16. Ermann M, Seiden D, Zammit G et al. (2006) An efficacy, safety and dose-response study of ramelteon In patients with chronic primray Insomnia. Sleep Med 7:17-24 (Pubitemid 43033540)
17. Franco KN, Messinger-Rapport B (2006) Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence. J Am Med Dir Assoc 7:201-202 (Pubitemid 43273659)
18. Frankl VE (1975) Paradoxical intention and dereflection. Psychotherapy: Theory, Research and Practice 12:226-237
19. Glass J, Lanctot K L, Herrmann N et al. (2005) Sedative hypnotics In older people with insomnia: Meta-analysis of risks and benefits. BMJ 331:1169-1175 (Pubitemid 41689427)
20. Hajak G (2006) Therapeutics of insomnia. New paradigms in pharmacological treatment of insomnia. Sleep Med 7 [Suppl 1]:20-26
21. Hajak G, Müller WE, Wittchen HU et al. (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics Zolpidem and Zopiclone - A review of case reports and epidemiological data, wiction 98:1371-1378
22. Hajak G, Rodenbeck A, Voderholzer U et al. (2001 ) Doxepin in the treatment of primary insomnia. J Clin Psychiat 62:453-463
23. Harvey AG, Payne S (2002) The management of unwanted pre-sleep thoughts in insomnia: Distraction with imagery versus general distraction. Behav Res Ther 40:267-277
24. Haupt M, Cruz-Jentoft A, Jeste D (2006) Mortality in elderly dementia patients treated with risperidone. J Clin Psychopharmacol 26:566-570 (Pubitemid 44772732)
25. Hauri PJ (1991 ) Case studies in insomnia. Plenum Medical Book Company, New York
26. Herxheimer A, Petrie KJ (2002) Melatonin for the prevention and treatment of jet lag, Issue 4, The Cochrane Library, Oxford
27. Holbrook AM, Crowther R, Lotter A et al. (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. Can Med Assoc J 162:225-233 (Pubitemid 30073249)
28. Irwin MR, Cole JC, Nicassio PM (2006) Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol 25:3-14
29. Jacobs GD, Pace-Schott EF, Stickgold R, Otto MW (2004) Cognitive behavior therapy and pharmacotherapy for insomnia: Arch Intern Med 164:1888-1896
30. Jeste DV, Blazer D, Casey D et al. (2007) ACNP white paper: Update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacology Epub ahead of print
31. Jordan W, Hajak G (1997) Gestörter Schlaf- Was tun? Ein Ratgeber, Arcis München
32. Kripke DF (2006) Risks of chronic hypnotic use. In: Lader M, Cardinali DP, Pandi-Perumal SR (eds) Sleep and sleep disorders - a neuropsychopharmacologuical approach. Springer, New York, pp 141-145
33. Krystal AD, Walsh JK, Laska E et al. (2003) Sustained efficacy of eszopiclonover 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study In adults with chronic insomnia. Sleep 26:793-799 (Pubitemid 39610622)
34. Krystal AD, Erman M, Zammit GK et al. (2008) Longterm efficacy and safety of Zolpidem extended-release 12,5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: A 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 31:79-90
35. Lange K, Wodarz N, Hajak G (2007) Abhängigkeitspotential der GABAa-Rezeptor-agonistischen Nichtbenzodiazepin-Hypnotika. Sucht 53(4):201 -213
36. Leger D, Laudon M, Zisapel N (2004) Nocturnal 6sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy. Am J Med 116:91-95 (Pubitemid 38056661)
37. McClusky HY, Milby JB, Switzer PK et al. (1991) Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia. Am J Psychiatry 148:121-126
38. McGechan A, Welligton K (2005) Ramelteon. CNS Drugs 19:1057-1065
39. Means MK, Lichstein KL, Epperson MT, Johnson CT (2000) Relaxation therapy for insomnia: Nighttime and daytime effects. Behav Res Ther 38:665-678 (Pubitemid 30249024)
40. Montgomery P, Dennis J (2004) A sytematic review of non-pharmacological therapies for sleep problems in later life. Sleep Med Rev 8:47-62 (Pubitemid 38313380)
41. Morin CM, CulbertJP, Schwartz SM (1994) Nonpharmacological interventions for insomnia: A meta-analysis of treatment efficacy. Am J Psychiatry 151:1172-1180 (Pubitemid 24240960)
42. Morin CM, Colecchi C, Stone J et al. (1999) Behavioral and pharmacological therapies for late-life insomnia. JAMA 281:991-999
43. Morin CM, Hauri PJ, Espie CA et al. (1999) Nonpharmacologic treatment of insomnia. Sleep 22:11341156
44. Morin CM, Bootzin RR, Buysse DJ et al. (2006) Psychological and behavioral treatment of insomnia: Update of the recent evidence (1998-2004). Sleep 29:1398-1414
45. Murtagh DR, Greenwood KM (1995) Identifying effective psychological treatments for insomnia: A meta-analysis. J Consult Clin Psychol 63:79-89
46. National Institutes of health state of the science conference statement (2005) Manifestations and management of chronic insomnia in adults. Sleep 28:1049-1057
47. Nowell PD, Mazumdar S, Buysse DJ et al. (1997) Benzodiazepines and Zolpidem for chronic insomnia: A meta-analysis of treatment efficacy. JAMA 278:2170-2177 (Pubitemid 28013492)
48. Ohne Autor (2003) Melatonin-controlled release - neurim pharmaceuticals. Circadin, melatoninprolonged release, melatonin-sustained release. Drugs R D 4:131-132
49. Pallesen S, Nordhus ICH, Kvale G (1998) Nonpharmacological Interventions for insomnia in older adults: A meta-analysis of treatment efficacy. Psychotherapy: Theory, Research, Practice, Training 35:472-482 (Pubitemid 29227719)
50. Perils ML, McCall WV, Krystal AD, Walsh JK (2004) Long-term, non-nightly administration of Zolpidem in the treatment nof patients with primary insomnia. J Clin Psychiatry 65:1128-1137
51. Perils ML, Jungquist C, Smith MT, Posner D (2005) Cognitive behavioural treatment of insomnia - A session-by-session guide, Springer, New York
52. Riemann D, Backhaus J (1996) Schlafstörungen bewältigen. Ein psychologisches Gruppenprogramm, Beltz PVU, Weinhelm
53. Riemann D, Voderholzer U, Cohrs S et al. (2002) Trimipramine in primary insomnia: Results of a Polysomnographic double-blind controlled study. Pharmacopsychiatry 35:165-174
54. Riemann D (2004) Ratgeber Schlafstörungen, Hogrefe, Göttingen
55. RothT, Seiden D, Sainati S et al. (2006) Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia. Sleep Med 7:312-318 (Pubitemid 43792892)
56. Roth T, Rogowski R, Hull Setal (2007) Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia. Sleep 30:1555-1561 (Pubitemid 350036981)
57. Sivertsen B, Omvik S, Pallesen S et al. (2006) Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults. JAMA 295:2851-2858
58. Smith MT, Perlis ML, Park A et al. (2002) Comparative meta-analysis of pharmacotherapy and behaviour therapy for persistent insomnia. Am J Psychiatry 159:5-11 (Pubitemid 41070720)
59. Spielman AJ, Saskin P,Thorpy MJ (1987) Treatment of chronic insomnia by restriction of time in bed. Sleep 10:45-56
60. Stevinson C, Ernst E (2000) Valerian for insomnia: A systematic review of randomized clinical trials. Sleep Med 1:91-99
61. Taibi DM, Landis CA, Petry H, Vitiello MV (2007) A systematic review of valerian as a sleep aid: Safe but not effective. Sleep Med Rev 11:209-232 (Pubitemid 46756375)
62. Walsh JK, Roth T, Randazzo A et al. (2000) Eight weeks of non-nightly use of Zolpidem for primary insomnia. Sleep 23:1087-1096 (Pubitemid 32046177)
63. Walsh JK, Erman M, Erwin M et al. (1998) Subjective hypnotic efficacy of trazodone and Zolpidem in DMS-III-R primary Insomnia. Hum Psychopharmacol 13:191-198 (Pubitemid 28216251)
64. Walsh JK, Schweitzer PK (1999) Ten-year trends in the pharmacological treatment of insomnia. Sleep 22:371-375 (Pubitemid 29230580)
65. Walsh JK (2004) Drugs used to treat insomnia in 2002: Regulatory-based rather than evidence-based medicine. Sleep 27:1441
66. Riemann D, Hajak G (2009) Insomnien I.Ätiologie, Pathophysiologie und Diagnostik. Nervenarzt (in press)